{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:10:11Z","timestamp":1768457411788,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013354","name":"Center for Drug Design, University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmcl.2019.126819","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:43:00Z","timestamp":1573558980000},"page":"126819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Structure activity relationship, 6-modified purine riboside analogues to activate hSTING, stimulator of interferon genes"],"prefix":"10.1016","volume":"30","author":[{"given":"Laurent F.","family":"Bonnac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine D.","family":"Dreis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.126819_b0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.it.2013.10.012","article-title":"Innate antiviral signalling in the central nervous system","volume":"35","author":"Carty","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bmcl.2019.126819_b0010","first-page":"87","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev"},{"key":"10.1016\/j.bmcl.2019.126819_b0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cytogfr.2014.08.004","article-title":"Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection","volume":"25","author":"Maringer","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bmcl.2019.126819_b0020","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmcl.2019.126819_b0025","first-page":"1","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","volume":"7","author":"Juan","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bmcl.2019.126819_b0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bmcl.2017.12.044","article-title":"Small molecule immuno-oncology therapeutic agents","volume":"28","author":"Toogood","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.126819_b0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbi.2019.07.004","article-title":"Efficacy and mechanism of cGAMP to suppress Alzheimer\u2019s disease by elevating TREM2","volume":"81","author":"Xu","year":"2019","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bmcl.2019.126819_b0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bmcl.2019.126819_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169631","article-title":"Antiviral efficacy and host immune response induction during sequential treatment with SB 9200 followed by entecavir in woodchucks","volume":"12","author":"Suresh","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2019.126819_b0050","first-page":"760","article-title":"STING: infection, inflammation and cancer","volume":"15","author":"Barber","year":"2015","journal-title":"Nat Rev"},{"key":"10.1016\/j.bmcl.2019.126819_b0055","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2019.126819_b0060","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1021\/acs.jmedchem.6b01300","article-title":"Design, synthesis, and biological evaluation of novel cyclic adenosine-inosine monophosphate (cAIMP) analogs that activate stimulator of interferon genes (STING)","volume":"59","author":"Lioux","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126819_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005324","article-title":"Characterization of a NOVEL HUMAN-SPECIFIC STING AGONIST THAT ELICITS ANTIVIRAL ACTIVITY AGAINST EMERGING ALPHAVIRUSES","volume":"11","author":"Sali","year":"2015","journal-title":"PLOS pathogens : a peer-reviewed open-access journal published by the Public Library of Science"},{"key":"10.1016\/j.bmcl.2019.126819_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2017.10.001","article-title":"A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists","volume":"147","author":"Liu","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2019.126819_b0075","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2019.126819_b0080","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1021\/cb400264n","article-title":"Anticancer flavonoids are mouse-selective STING agonists","volume":"8","author":"Kim","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2019.126819_b0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.immuni.2016.02.004","article-title":"The Vaccine adjuvant chitosan promotes cellular immunity via DNA Sensor cGAS-STING-dependent induction of type I interferons","volume":"44","author":"Carroll","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.bmcl.2019.126819_b0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-2952(77)90192-7","article-title":"Tight-binding inhibitors\u2014IV. Inhibition of adenosine deaminases by various inhibitors","volume":"26","author":"Agarwal","year":"1977","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2019.126819_b0095","first-page":"71","article-title":"Inhibitors of nucleoside and nucleotide metabolism","volume":"3","author":"Henderson","year":"1973","journal-title":"Cancer Chemotherapy Rep"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19307887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:35:32Z","timestamp":1760772932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19307887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0960894X19307887"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126819","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure activity relationship, 6-modified purine riboside analogues to activate hSTING, stimulator of interferon genes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"126819"}}